期刊文献+

美沙拉嗪联合云南白药灌肠对溃疡性结肠炎患者的临床研究 被引量:3

Clinical Research of Mesalazine Combined with Yunnanbaiyao Powder Coloclysis on Patients with Ulcerative Colitis
下载PDF
导出
摘要 目的观察美沙拉嗪联合云南白药灌肠对溃疡性结肠炎(UC)的临床疗效。方法 42例UC患者随机分对照组和治疗组,每组21例,前组予美沙拉嗪,后组予美沙拉嗪联合云南白药保留灌肠,观察患者治疗前后临床症状,血清C反应蛋白(CRP)和肿瘤坏死因子-α(TNF-α),以及结肠的病理变化。结果两组患者治疗后临床症状、血清CRP和TNF-α水平,以及结肠病理损伤均较治疗前均改善,治疗组疗效更佳,总有效率为95.23%,与对照组比较有统计学意义(76.2%,P<0.05)。结论美沙拉嗪联合云南白药保留灌肠对减轻UC患者的炎性反应,改善临床症状和肠道病理损伤疗效显著,该疗法值得临床推广。 Objective To approach the clinical effect of mesalazine combined with traditional chinese enema on pateints with ulcerative colitis (UC) . Methods Forty-two UC patients were randomly divided into control group and treatment group, 21 cases in each group, the former group was accepted mesalazine therapy, the later group was treated with mesalazine and yunnanbaiyao powder retention enema, the serum levels of C reactive protein (CRP) and tumor necrosis factor-α (TNF-α) were tested by rate nephelometry and elisa respectively, colonoscopy and colon tissue HE staining were undertook before and after treatment. Results The clinical symptoms relief, serum CPR and TNF-α levels and colonic pathological damages were improved significantly after treatment in two groups, the total effective rate was 95.23% in treatment group, which had significant difference comparing with that in control group (76.2%, P〈0.05) . Conclusion The therapy of mesalazine combined with yunnanbaiyao powder retention enema can effectively lesson inflammation, reduce intestinal pathological damage and relieve clinical symptoms of patients with UC, which is worth for generalization in clinic.
机构地区 广州新海医院
出处 《中国医药指南》 2012年第19期40-41,共2页 Guide of China Medicine
关键词 溃疡性结肠炎 肿瘤坏死因子-Α 美沙拉嗪 云南白药 保留灌肠 Ulcerative colitis Tumor necrosis factor-α Mesalazine Yunnanbaiyao powder Retention enema
  • 相关文献

参考文献11

  • 1Sandor Z,Deng XM,Khomenko T,et al.Altered angiogenic balance in ulcer ative colitis:a key to impaired healing[J].Biochem Biophys Res Commun,2006,350 (1):147-150.
  • 2López-Palacios N,Mendoza JL,Taxonera C,et al.Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy[J].Eur J Intern Med,2011,22(6):621-625.
  • 3Peyrin-Biroulet L,Gonzalez F,Dubuquoy L,et al.Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease[J].Gut,2012,61(1):78-85.
  • 4Gombo(s)ová L,Lazúrová I,Zakuciová M,et al.Genes of intestinal Escherichia coli and their relation to the inflammatory activity in patients with ulcerative colitis and Crohn's disease[J].Folia Microbiol (Praha),2011,56(5):367-372.
  • 5Sandborn WJ,Hanauer SB.Systematic Review:the Pharm-Cokinetie Profiles of Oral Mesalazine Formulations and Mesala.zinepro-drugs Used in the Management of Ulcer ative Colitis[J].Aliment Pharmacol Ther,2003,17(1):29.
  • 6张晓博,杨宪武,党惠娇,吴国斌,李红玉,徐志斌,吴明利.IL-8和TNF-α在美沙拉嗪和美常安胶囊在治疗溃疡性结肠炎患者血清中表达变化[J].河北医药,2010,32(5):589-590. 被引量:12
  • 7Gisbe JP,Gomollon F,Mate J,et al.Role of 5 aminosali-cylieacid in treatment of inflammatory bowel disease:a systematic review[J].Dig Dis Sci,2002,47(3):471.
  • 8卢晨霞,施正君.美沙拉嗪联合中药灌肠治疗溃疡性结肠炎疗效观察[J].浙江临床医学,2011,13(8):918-919. 被引量:8
  • 9王雨来,杜国安,刘邦强.云南白药现代医学应用概述[J].时珍国医国药,2006,17(12):2580-2582. 被引量:16
  • 10李明峰.中药保留灌肠治疗溃疡性结肠炎50例分析[J].实用中医内科杂志,2008,22(2):27-27. 被引量:17

二级参考文献53

共引文献50

同被引文献29

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部